- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Franklin Lakes Today
By the People, for the People
SG Americas Securities Acquires Stake in Embecta Corp.
Investment firm buys over 435,000 shares in diabetes care company
Apr. 2, 2026 at 9:03am
Got story updates? Submit your updates here. ›
SG Americas Securities LLC has acquired a new position in Embecta Corp. (NASDAQ:EMBC), purchasing 435,842 shares of the diabetes care company's stock in the fourth quarter. The transaction, valued at approximately $5.18 million, gives SG Americas Securities a 0.74% ownership stake in Embecta.
Why it matters
This investment signals institutional confidence in Embecta's growth potential as a pure-play diabetes care company following its spin-off from Becton, Dickinson and Company in 2021. Embecta's product portfolio of insulin delivery and glucose monitoring devices positions it to benefit from the rising global prevalence of diabetes.
The details
According to a recent SEC filing, SG Americas Securities LLC purchased the 435,842 shares of Embecta in the fourth quarter of 2022. This represents approximately 0.74% of the company's outstanding stock. Embecta, headquartered in Franklin Lakes, New Jersey, focuses exclusively on the development, manufacturing, and commercialization of diabetes care products such as insulin infusion sets, pumps, pen needles, and glucose test strips.
- SG Americas Securities LLC acquired the Embecta shares in the fourth quarter of 2022.
- Embecta was spun off from Becton, Dickinson and Company on July 1, 2021.
The players
SG Americas Securities LLC
An investment firm that has acquired a new position in Embecta Corp., purchasing over 435,000 shares of the diabetes care company's stock.
Embecta Corp.
A pure-play diabetes care company that was spun off from Becton, Dickinson and Company in 2021, focusing on the development and manufacturing of insulin delivery and glucose monitoring devices.
The takeaway
SG Americas Securities' acquisition of a significant stake in Embecta underscores the investment community's optimism about the company's future as a dedicated diabetes care provider, poised to capitalize on the rising global prevalence of the condition.
